|Assessment Status||Rapid Review complete|
|Indication||Treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy.|
|Rapid review commissioned||25/07/2017|
|Rapid review completed||29/08/2017|
|Rapid review outcome||Full pharmacoeconomic assessment recommended at submitted price|
The HSE has approved reimbursement following confidential price negotiations January 2018.